| 1 |
GBD 2023 Chronic Kidney Disease Collaborators. Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023[J]. Lancet, 2025，406(10518)：2461-2482.
|
| 2 |
黄洁夫． 中国器官捐献和移植发展报告(2024)[M]. 北京：清华大学出版社，2025: 3-26.
|
| 3 |
Spiers J, Smith JA. Waiting for a kidney from a deceased donor: an interpretative phenomenological analysis[J]. Psychol Health Med, 2016, 21(7): 836-844.
|
| 4 |
中华医学会器官移植学分会. 肾移植操作技术规范(2019版)——适应证、禁忌证、术前检查和准备[J]. 器官移植，2019，10(5)：469-472.
|
| 5 |
Ahmadmehrabi S, Tang WHW. Hemodialysis-induced cardiovascular disease[J]. Semin Dial, 2018，31(3)：258-267.
|
| 6 |
Agarwal PK, Hellemons ME, Zelle DM ，et al. Smoking is a risk factor for graft failure and mortality after renal transplantation[J].Am J Nephrol, 2011, 34(1)：26-31.
|
| 7 |
Chadban SJ, Ahn C, Axelrod DA, et al. KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation[J]. Transplantation, 2020, 104(4S1): S11-S103.
|
| 8 |
Banas MC, Banas B, Wolf J, et al. Smoking behaviour of patients before and after renal transplantation[J]. Nephrol Dial Transplant, 2008, 23(4): 1442-1446.
|
| 9 |
Khalil MAM, Tan J, Khamis S，et al. Cigarette smoking and its hazards in kidney transplantation[J]. Adv Med, 2017：6213814.
|
| 10 |
Pascual J, Abramowicz D, Cochat P, et al. European renal best practice guideline on the management and evaluation of the kidney donor and recipient[J]. Nefrologia, 2014, 34(3): 293-301.
|
| 11 |
Huang M, Lv A, Wang J, et al. Exercise training and outcomes in hemodialysis patients: systematic review and meta-analysis[J]. Am J Nephrol, 2019, 50(4): 240-254.
|
| 12 |
Ashby D, Borman N, Burton J, et al. Renal association clinical practice guideline on haemodialysis[J]. BMC Nephrol, 2019, 20(1)：379.
|
| 13 |
中国医师协会康复医师分会肾康复专业委员会. 我国成人慢性肾脏病患者运动康复的专家共识[J]. 中华肾脏病杂志，2019, 35(7): 537-543.
|
| 14 |
Bennett PN, Bohm C, Harasemiw O, et al. Physical activity and exercise in peritoneal dialysis: International Society for Peritoneal Dialysis and the Global Renal Exercise Network practice recommendations[J]. Perit Dial Int, 2022, 42(1): 8-24.
|
| 15 |
Carrero JJ, Thomas F, Nagy K, et al. Global prevalence of protein-energy wasting in kidney disease: a meta-analysis of contemporary observational studies from the international society of renal nutrition and metabolism[J]. J Ren Nutr, 2018, 28(6)：380-392.
|
| 16 |
Beto JA, Ramirez WE, Bansal VK. Medical nutrition therapy in adults with chronic kidney disease: integrating evidence and consensus into practice for the generalist registered dietitian nutritionist[J]. J Acad Nutr Diet, 2014, 114(7): 1077-1087.
|
| 17 |
中国医师协会肾脏内科医师分会，中国中西医结合学会肾脏疾病专业委员会营养治疗指南专家协作组. 中国慢性肾脏病营养治疗临床实践指南(2021版)[J]. 中华医学杂志，2021, 101(8): 539-559.
|
| 18 |
Krishnan N, Higgins R, Short A, et al. Kidney transplantation significantly improves patient and graft survival irrespective of BMI: a cohort study[J]. Am J Transplant, 2015, 15(9): 2378- 2386.
|
| 19 |
Abramowicz D, Cochat P, Claas FH, et al. European renal best practice guideline on kidney donor and recipient evaluation and perioperative care[J]. Nephrol Dial Transplant, 2015, 30: 1790-1797.
|
| 20 |
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension [J]. J Hypertens, 2018, 36(10)：1953-2041.
|
| 21 |
Parati G, Ochoa JE, Bilo G, et al. Hypertension in chronic kidney disease part 1: out-of-office blood pressure monitoring: methods, thresholds, and patterns[J]. Hypertension, 2016, 67(6)：1093-1101.
|
| 22 |
慢性肾脏病高血压管理共识专家组. 非透析和透析慢性肾脏病患者高血压管理的中国专家共识[J]. 中华内科杂志，2023, 62(7)：748-774.
|
| 23 |
Auñón P, Cavero T, García A, et al. Kidney transplantation outcomes of patients with chronic hypotension in dialysis[J]. Kidney Int Rep, 2024, 9(6): 1742-1751.
|
| 24 |
中国医药教育协会肾病与血液净化专业委员会血液透析低血压防治专家组. 血液透析中低血压防治专家共识(2022)[J]. 中华内科杂志，2022, 61(3)：269-281.
|
| 25 |
Huang AA, Zahid JO, Haji M, et al. Association of pre-existing type 2 diabetes on kidney transplant outcomes and factors correlating with survival: a single-center analysis[J]. J Surg Res, 2024, 303: 268-274.
|
| 26 |
Cascais de Sá D, Santos L, Rodrigues L, et al. Post-kidney-transplant diabetes: evaluation of risk factors[J]. Transplant Proc, 2019, 51(5)：1597-1600.
|
| 27 |
Conte C, Secchi A. Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention[J]. Acta Diabetol, 2018, 55(8)：763-779.
|
| 28 |
王翔宇，张倩，薛耀明. 终末期肾病患者糖代谢紊乱的研究进展[J]. 中华糖尿病杂志，2021, 13(1): 10-13.
|
| 29 |
《中国围透析期慢性肾脏病管理规范》专家组. 中国围透析期慢性肾脏病管理规范[J].中华肾脏病杂志，2021, 37(8): 690-704.
|
| 30 |
中华医学会糖尿病学分会，中华医学会内分泌学分会. 中国成人2型糖尿病患者糖化血红蛋白控制目标及达标策略专家共识[J]. 中华糖尿病杂志，2020, 12(1): 1-12.
|
| 31 |
Yang WL, Zhu XY, Zhu N, et al. What's the optimal lipids level for dialysis patients? A cohort study from a Chinese dialysis center in a university hospital[J]. PLoS One, 2016, 11(12): e0167258.
|
| 32 |
Farbakhsh K, Kasiske BL. Dyslipidemias in patients who have chronic kidney disease[J]. Med Clin North Am, 2005, 89(3)：689-699.
|
| 33 |
Reiner Z, Catapano AL, De Backer G, et al. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)[J]. Eur Heart J, 2011, 32(14): 1769-1818.
|
| 34 |
中华医学会器官移植学分会. 中国肾脏移植等待者及受者疫苗接种指南[J]. 器官移植，2025, 16(2)：177-190.
|
| 35 |
Mikhail A, Brown C, Williams JA, et al. Renal association clinical practice guideline on anaemia of chronic kidney disease[J]. BMC Nephrol, 2017, 18(1)：345.
|
| 36 |
Locatelli F, Bárány P, Covic A, et al. Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European renal best practice position statement[J]. Nephrol Dial Transplant, 2013, 28(6)：1346-1359.
|
| 37 |
KDOQI, National Kidney Foundation. Ⅱ. Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults[J]. Am J Kidney Dis, 2006, 47(5 Suppl 3)：S16-S85.
|
| 38 |
Zivcić-Cosić S, Fućak M, Orlić P, et al. Evaluation and selection of candidates for renal transplantation at the Clinical Hospital Center in Rijeka[J]. Acta Med Croatica, 2003, 57(1)：65-68.
|
| 39 |
孙毅，朱泽善，张浩军. 血液透析患者导管相关感染危险因素及风险预测模型研究进展[J]. 中华医院感染学杂志，2025, 35(8): 1261-1267.
|
| 40 |
Dhingra RK, Young EW, Hulbert-Shearon TE, et al. Type of vascular access and mortality in U．S. hemodialysis patients[J]. Kidney Int, 2001，60(4)：1443-1451.
|
| 41 |
Ravani P, Palmer SC, Oliver MJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review[J]. J Am Soc Nephrol, 2013, 24(3)：465-473.
|
| 42 |
董永泽，许秀君，沈华娟，等. 维持性血液透析患者动静脉血管通路穿刺管理的最佳证据总结[J]. 中华护理杂志，2023，58(9)：1135-1141.
|
| 43 |
Li PK, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment[J]. Perit Dial Int, 2022, 42(2): 110-153.
|
| 44 |
张玉帅． 肾移植等待者继发性甲状旁腺功能亢进的治疗研究进展[J]. 肾脏病与透析肾移植杂志，2023，32(4)：388-393.
|
| 45 |
Ivarsson KM, Clyne N, Almquist M, et al. Hyperparathyroidism and new onset diabetes after renal transplantation[J]. Transplant Proc, 2014, 46(1) : 145-150.
|
| 46 |
Fukagawa M, Yokoyama K, Koiwa F, et al. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder[J]. Ther Apher Dial, 2013, 17(3): 247288.
|
| 47 |
郑守华． 继发性甲状旁腺功能亢进症甲状旁腺切除加前臂移植术的临床和机制研究[D]. 郑州：郑州大学，2016.
|
| 48 |
Okada M, Hiramitsu T, Ichimori T, et al. Comparison of preand post-transplant parathyroidectomy in renal transplant recipients and the impact of parathyroidectomy timing on calcium metabolism and renal allograft function[J]. World J Surg, 2020，44 (2) ：498-507.
|
| 49 |
中华医学会器官移植学分会. 中国ABO血型不相容活体亲属肾脏移植临床诊疗指南(2023版)[J]. 中华器官移植杂志，2024, 45(11)：752-762.
|
| 50 |
石炳毅． 组织配型在器官移植领域中应用发展的历史沿革[J]. 中华医学杂志，2019, 99(12): 881883.
|
| 51 |
中国医药生物技术协会移植技术分会，上海市肾脏移植质控中心专家委员会. 肾移植人类白细胞抗原分型和抗体检测专家共识[J]. 中华医学杂志，2022，102(10)：704-716.
|
| 52 |
Scheel J, Reber S, Stoessel L, et al. Patient-reported non-adherence and immunosuppressant trough levels are associated with rejection after renal transplantation[J]. BMC Nephrol, 2017, 18(1)：107.
|
| 53 |
车旭，乔东鸽，王红霞，等. 维持性血液透析患者治疗依从性影响因素结构方程模型构建与验证[J]. 中华护理杂志，2024, 59(5)：562-569.
|
| 54 |
涂金鹏． 《改善全球肾脏病预后组织(KDIGO)：肾移植候选者评估和管理临床实践指南(2020版)》解读[J/OL]. 实用器官移植电子杂志，2021，9(6)：431-435.
|
| 55 |
De Pasquale C, Pistorio ML, Veroux M, et al. Psychological and psychopathological aspects of kidney transplantation: a systematic review[J]. Front Psychiatry, 2020, 11：106.
|
| 56 |
Segall L, Nistor I, Pascual J, et al. Criteria for and appropriateness of renal transplantation in elderly patients with end-stage renal disease: a literature review and position statement on Behalf of the European Renal Association-European Dialysis and Transplant Association Descartes Working Group and European Renal Best Practice[J]. Transplantation, 2016, 100(10)：e55-e65.
|